GLUE
(NASDAQ)Monte Rosa Therapeutics, Inc.
---- (--)
Loading... - Market loading
Monte Rosa Therapeutics (GLUE) Stock Price & Financial Analysis
Monte Rosa Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$17.79 - $19.24
52-Week High$25.77
52-Week Low$3.50
Open$18.78
Volume743.13K
Average Volume (3M)743.13K
Market Cap1.11B
Shares Outstanding61.79M
P/E Ratio (TTM)52.86
Price to Sales (P/S)6.10
Price to Book (P/B)4.50
EV/EBITDA47.88
Revenue (TTM)181.54M
Net Income (TTM)20.95M
Free Cash Flow (TTM)145.39M
EPS (TTM)$0.34
Profit Margin11.54%
Operating Margin4.69%
Return on Equity (ROE)8.52%
Debt to Equity0.16
50-Day MA$19.41
200-Day MA$10.12
52-Week Change166.67%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Day's Range$17.79 - $19.24
52-Week High$25.77
52-Week Low$3.50
Open$18.78
Volume743.13K
Average Volume (3M)743.13K
Market Cap1.11B
Shares Outstanding61.79M
P/E Ratio (TTM)52.86
Price to Sales (P/S)6.10
Price to Book (P/B)4.50
EV/EBITDA47.88
Revenue (TTM)181.54M
Net Income (TTM)20.95M
Free Cash Flow (TTM)145.39M
EPS (TTM)$0.34
Profit Margin11.54%
Operating Margin4.69%
Return on Equity (ROE)8.52%
Debt to Equity0.16
50-Day MA$19.41
200-Day MA$10.12
52-Week Change166.67%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Latest News
Recent news and articles about GLUE